172 related articles for article (PubMed ID: 20306001)
1. Clinical trials for early (pre-dementia) Alzheimer's disease: a case for mild cognitive impairment.
Petersen RC
J Nutr Health Aging; 2010 Apr; 14(4):304-5. PubMed ID: 20306001
[TBL] [Abstract][Full Text] [Related]
2. Seeing with new eyes: finding a path to early intervention trials in Alzheimer's disease.
Cedarbaum JM; Crans G; Grundman M
J Nutr Health Aging; 2010 Apr; 14(4):306-9. PubMed ID: 20306002
[TBL] [Abstract][Full Text] [Related]
3. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.
Bradfield NI; Ellis KA; Savage G; Maruff P; Burnham S; Darby D; Lautenschlager NT; Martins RN; Masters CL; Rainey-Smith SR; Robertson J; Rowe C; Woodward M; Ames D
Alzheimer Dis Assoc Disord; 2018; 32(3):190-196. PubMed ID: 29561277
[TBL] [Abstract][Full Text] [Related]
4. The potential and limits for clinical trials for early Alzheimer's disease and some recommendations.
Schneider LS
J Nutr Health Aging; 2010 Apr; 14(4):295-8. PubMed ID: 20305999
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment.
Forlenza OV; Diniz BS; Talib LL; Radanovic M; Yassuda MS; Ojopi EB; Gattaz WF
Braz J Psychiatry; 2010 Sep; 32(3):216-22. PubMed ID: 20414590
[TBL] [Abstract][Full Text] [Related]
6. Pre-dementia Alzheimer's trials: overview.
Aisen PS
J Nutr Health Aging; 2010 Apr; 14(4):294. PubMed ID: 20305998
[TBL] [Abstract][Full Text] [Related]
7. Evolving early (pre-dementia) Alzheimer's disease trials: suit the outcomes to the population and study design.
Doody RS
J Nutr Health Aging; 2010 Apr; 14(4):299-302. PubMed ID: 20306000
[TBL] [Abstract][Full Text] [Related]
8. Reliability and validity of A Quick Test of Cognitive Speed for detecting early-stage dementia in elderly Japanese.
Takahashi F; Awata S; Sakuma N; Inagaki H; Ijuin M
Psychogeriatrics; 2012 Jun; 12(2):75-82. PubMed ID: 22712639
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
[TBL] [Abstract][Full Text] [Related]
10. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
[TBL] [Abstract][Full Text] [Related]
11. A comparison of emotional decoding abilities in patients with amnestic mild cognitive impairment, very mild and mild Alzheimer's disease.
Klimkowicz-Mrowiec A; Krzywoszanski L; Spisak K; Donohue BE; Szczudlik A; Slowik A
Curr Alzheimer Res; 2014 Feb; 11(2):200-5. PubMed ID: 24359502
[TBL] [Abstract][Full Text] [Related]
12. Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.
Kennedy RE; Cutter GR; Schneider LS
Alzheimers Dement; 2014 May; 10(3):349-59. PubMed ID: 23712001
[TBL] [Abstract][Full Text] [Related]
13. A Biomarker Combining Imaging and Neuropsychological Assessment for Tracking Early Alzheimer's Disease in Clinical Trials.
Verma N; Beretvas SN; Pascual B; Masdeu JC; Markey MK;
Curr Alzheimer Res; 2018 Mar; 15(5):429-442. PubMed ID: 29110613
[TBL] [Abstract][Full Text] [Related]
14. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the Risk Factors for Progression from Amyloid-Negative Amnestic Mild Cognitive Impairment to Dementia.
Kim HJ; Lee JH; Cheong EN; Chung SE; Jo S; Shim WH; Hong YJ
Curr Alzheimer Res; 2020; 17(10):893-903. PubMed ID: 33256581
[TBL] [Abstract][Full Text] [Related]
16. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
[TBL] [Abstract][Full Text] [Related]
17. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
[TBL] [Abstract][Full Text] [Related]
18. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
19. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
Modrego PJ; Fayed N; Pina MA
Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
[TBL] [Abstract][Full Text] [Related]
20. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve.
Querbes O; Aubry F; Pariente J; Lotterie JA; Démonet JF; Duret V; Puel M; Berry I; Fort JC; Celsis P;
Brain; 2009 Aug; 132(Pt 8):2036-47. PubMed ID: 19439419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
